financetom
Business
financetom
/
Business
/
Sapiens Stock Is Trading Higher Wednesday: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sapiens Stock Is Trading Higher Wednesday: What's Going On?
Aug 13, 2025 1:06 PM

Sapiens International ( SPNS ) shares are trading higher Wednesday after Advent agreed to acquire the company in a $2.5 billion deal.

What To Know: Under the terms of the agreement, Sapiens shareholders will receive $43.50 per share in cash, a 64% premium to the company's undisturbed closing share price of $26.52 on Aug. 8. The deal has been unanimously approved by Sapiens' board of directors, and existing shareholder Formula Systems will retain a minority stake in the company.

Sapiens said Advent's investment will help accelerate innovation in its SaaS-based insurance solutions and expand its global reach. Upon completion of the transaction, Sapiens' common shares will no longer be publicly listed, and the company will operate as a privately held business.

The acquisition is expected to close in the fourth quarter of 2025 or the first quarter of 2026, pending shareholder and regulatory approvals. Advent has arranged committed debt and equity financing to fund the deal, including $1.3 billion in equity contributions from funds it advises.

See Also: What Does the Market Think About Coupang?

SPNS Price Action: At the time of writing, Sapiens stock is trading 44.34% higher at $42.58, according to data from Benzinga Pro.

This illustration was generated using artificial intelligence via Midjourney.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
South Korea seeks incentives for long-term stock investment, FX stability
South Korea seeks incentives for long-term stock investment, FX stability
Nov 18, 2025
SEOUL (Reuters) -South Korea will prepare incentives for long-term stock investors, while making efforts toward foreign exchange stability, the finance minister said on Wednesday. We plan to introduce incentive measures for small investors, who stay in capital markets for a long time or invest in certain stocks in the long term, Minister Koo Yun-cheol said at a meeting with reporters....
Aptose Biosciences Announces Arrangement Agreement for Acquisition by Hanmi Pharmaceutical
Aptose Biosciences Announces Arrangement Agreement for Acquisition by Hanmi Pharmaceutical
Nov 18, 2025
SAN DIEGO and TORONTO, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ( APTOF ) (“Aptose” or the “Company”) and Hanmi Pharmaceutical Co. Ltd. (“Hanmi”) today announced that Aptose, Hanmi and HS North America Ltd., a wholly owned subsidiary of Hanmi (“Hanmi Purchaser” and together with Hanmi, the “Hanmi Purchasers”), have entered into a definitive arrangement agreement (the “Arrangement...
China raises $4.6 billion in euro bonds on strong investor demand
China raises $4.6 billion in euro bonds on strong investor demand
Nov 18, 2025
SYDNEY, Nov 19 (Reuters) - China has raised 4 billion euros ($4.6 billion) in a two-tranche bond issuance with strong demand from investors despite a spike in global market volatility, according to a term sheet reviewed by Reuters on Wednesday. A four-year tranche raised 2 billion euros at the mid-swap rate plus 5 basis points, the term sheet showed. The...
BRIEF-Aptose Biosciences Announces Arrangement Agreement For Acquisition By Hanmi Pharmaceutical
BRIEF-Aptose Biosciences Announces Arrangement Agreement For Acquisition By Hanmi Pharmaceutical
Nov 18, 2025
Nov 19 (Reuters) - Aptose Biosciences Inc ( APTOF ): * APTOSE BIOSCIENCES ANNOUNCES ARRANGEMENT AGREEMENT FOR ACQUISITION BY HANMI PHARMACEUTICAL * APTOSE BIOSCIENCES INC ( APTOF ) - SHAREHOLDERS TO RECEIVE C$2.41 PER SHARE, 28% PREMIUM * APTOSE BIOSCIENCES INC ( APTOF ) - HANMI PURCHASER TO BUY ALL OUTSTANDING APTOSE SHARES Source text: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved